Endoscopic transsphenoidal pituitary surgery: A good and safe primary treatment option for Cushing's disease, even in case of macroadenomas or invasive adenomas

European Journal of Endocrinology

Volumn 169, Issue 3, 2013, Pages 329-337

  Wagenmakers, M A E M ^a   Boogaarts, H D ^b   Roerink, S H P P ^a   Timmers, H J L M ^a   Stikkelbroeck, N M M L ^a   Smit, J W A ^a   Van Lindert, E J ^b   Netea Maier, R T ^a   Grotenhuis, J A ^b   Hermus, A R M M ^a  

^a Department of Medicine   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; ANTIBIOTIC AGENT; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DESMOPRESSIN; DEXAMETHASONE; ESTRADIOL; GLUCOCORTICOID; GONADOTROPIN; GROWTH HORMONE; HYDROCORTISONE; HYPOPHYSIS HORMONE; KETOCONAZOLE; LEVOTHYROXINE; METYRAPONE; PREDNISOLONE; SOMATOMEDIN C; TESTOSTERONE; THYROTROPIN; THYROXINE; VASOPRESSIN;

ADENOMA; ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CUSHING DISEASE; DIABETES INSIPIDUS; DIET RESTRICTION; DISEASE CLASSIFICATION; DRUG DOSE REDUCTION; DRUG MEGADOSE; ENDOSCOPIC SURGERY; ENDOSCOPIC TRANSSPHENOIDAL PITUITARY SURGERY; FEMALE; FOLLOW UP; GLUCOCORTICOSTEROID DEFICIENCY; HORMONAL THERAPY; HORMONE DEFICIENCY; HORMONE RELEASE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERCORTISOLISM; HYPONATREMIA; INVASIVE ADENOMA; LIQUORRHEA; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NUCLEAR MAGNETIC RESONANCE IMAGING; PEROPERATIVE COMPLICATION; POLYURIA; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; REMISSION; RETROSPECTIVE STUDY; SAFETY; SURGICAL TECHNIQUE; SYMPTOMATOLOGY; TRANSSPHENOIDAL SURGERY; TREATMENT FAILURE; TREATMENT INDICATION; URINARY TRACT INFECTION;

ACTH-SECRETING PITUITARY ADENOMA; ADENOMA; ADULT; CAVERNOUS SINUS; COHORT STUDIES; DEXAMETHASONE; ENDOSCOPY; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; MALE; MEDICAL RECORDS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NETHERLANDS; PITUITARY ACTH HYPERSECRETION; PITUITARY GLAND; REMISSION INDUCTION; RETROSPECTIVE STUDIES;

EID: 84883342052     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0325     Document Type: Article

References (39)

1. Dekkers OM, Biermasz NR, Pereira AM, Roelfsema F, van AkenMO, Voormolen JH & Romijn JA. Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma. Journal of Clinical Endocrinology and Metabolism 2007 92 976-981. (doi:10.1210/jc.2006-2112)
2. Lindholm J, Juul S, Jorgensen JO, Astrup J, Bjerre P, Feldt-Rasmussen U, Hagen C, Jorgensen J, Kosteljanetz M, Kristensen L et al. Incidence and late prognosis of Cushing's syndrome: a population-based study. Journal of Clinical Endocrinology and Metabolism 2001 86 117-123. (doi:10.1210/jc.86.1.117)
3. Hassan-Smith ZK, Sherlock M, Reulen RC, Arlt W, Ayuk J, Toogood AA, Cooper MS, Johnson AP & Stewart PM. Outcome of Cushing's disease following transsphenoidal surgery in a single center over 20 years. Journal of Clinical Endocrinology and Metabolism 2012 97 1194-1201. (doi:10.1210/jc.2011-2957)
4. Mehta GU, Lonser RR & Oldfield EH. The history of pituitary surgery for Cushing disease. Journal of Neurosurgery 2012 116 261-268. (doi:10.3171/2011.8.JNS102005)
5. Alwani RA, de Herder WW, van Aken MO, van den Berge JH, Delwel EJ, Dallenga AH, De Jong FH, Lamberts SW, van der Lely AJ & Feelders RA. Biochemical predictors of outcome of pituitary surgery for Cushing's disease. Neuroendocrinology 2010 91 169-178. (doi:10.1159/000258677)
6. Chen JC, Amar AP, Choi S, Singer P, Couldwell WT & Weiss MH. Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test. Journal of Neurosurgery 2003 98 967-973. (doi:10.3171/jns.2003.98.5. 0967)
7. Ciric I, Zhao JC, Du H, Findling JW, Molitch ME, Weiss RE, Refetoff S, Kerr WD & Meyer J. Transsphenoidal surgery for Cushing disease: experience with 136 patients. Neurosurgery 2012 70 70-80 (discussion 80-81). (doi:10.1227/NEU.0b013e318 22dda2c)
8. Esposito F, Dusick JR, Cohan P, Moftakhar P, McArthur D,Wang C, Swerdloff RS & Kelly DF. Clinical review: early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing's disease. Journal of Clinical Endocrinology and Metabolism 2006 91 7-13. (doi:10.1210/jc.2005-1204)
9. Hammer GD, Tyrrell JB, Lamborn KR, Applebury CB, Hannegan ET, Bell S, Rahl R, Lu A & Wilson CB. Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results. Journal of Clinical Endocrinology and Metabolism 2004 89 6348-6357. (doi:10.1210/jc.2003-032180)
10. Honegger J, Schmalisch K, Beuschlein F, Kaufmann S, Schnauder G, Naegele T & Psaras T. Contemporary microsurgical concept for the treatment of Cushing's disease: endocrine outcome in 83 consecutive patients. Clinical Endocrinology 2012 76 560-567. (doi:10.1111/j.1365-2265.2011.04268.x)
11. Patil CG, Prevedello DM, Lad SP, Vance ML, Thorner MO, Katznelson L & Laws ER Jr. Late recurrences of Cushing's disease after initial successful transsphenoidal surgery. Journal of Clinical Endocrinology and Metabolism 2008 93 358-362. (doi:10.1210/jc.2007-2013)
12. Prevedello DM, Pouratian N, Sherman J, Jane JA Jr, Vance ML, Lopes MB & Laws ER Jr. Management of Cushing's disease: outcome in patients with microadenoma detected on pituitary magnetic resonance imaging. Journal of Neurosurgery 2008 109 751-759. (doi:10.3171/JNS/2008/109/10/0751)
13. Rees DA, Hanna FW, Davies JS, Mills RG, Vafidis J & Scanlon MF. Long-termfollow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission. Clinical Endocrinology 2002 56 541-551. (doi:10.1046/j.1365-2265. 2002.01511.x)
14. Rollin G, Ferreira NP & Czepielewski MA. Prospective evaluation of transsphenoidal pituitary surgery in 108 patients with Cushing's disease. Arquivos Brasileiros de Endocrinologia e Metabologia 2007 51 1355-1361. (doi:10.1590/S0004-27302007000800022)
15. Shimon I, Ram Z, Cohen ZR & Hadani M. Transsphenoidal surgery for Cushing's disease: endocrinological follow-up monitoring of 82 patients. Neurosurgery 2002 51 57-61 (discussion 61-62). (doi:10.1097/00006123-200207000- 00008)
16. Swearingen B, Biller BM, Barker FG II, Katznelson L, Grinspoon S, Klibanski A & Zervas NT. Long-term mortality after transsphenoidal surgery for Cushing disease. Annals of Internal Medicine 1999 130 821-824. (doi:10.7326/0003-4819-130-10-199905180-00015)
17. Feelders RA, Hofland LJ & de Herder WW. Medical treatment of Cushing's syndrome: adrenal-blocking drugs and ketaconazole. Neuroendocrinology 2010 92 (Suppl 1) 111-115. (doi:10.1159/000314292)
18. Tabaee A, Anand VK, Barron Y, Hiltzik DH, Brown SM, Kacker A, Mazumdar M & Schwartz TH. Endoscopic pituitary surgery: a systematic review and meta-analysis. Journal of Neurosurgery 2009 111 545-554. (doi:10.3171/2007.12. 17635)
19. DeKlotz TR, Chia SH, LuW, Makambi KH, Aulisi E & Deeb Z. Metaanalysis of endoscopic versus sublabial pituitary surgery. Laryngoscope 2012 122 511-518. (doi:10.1002/lary.22479)
20. Dehdashti AR, Ganna A, Karabatsou K & Gentili F. Pure endoscopic endonasal approach for pituitary adenomas: early surgical results in 200 patients and comparison with previous microsurgical series. Neurosurgery 2008 62 1006-1015 (discussion 1015-1017). (doi:10.1227/01.neu.0000325862. 83961.12)
21. Jane JA Jr, Starke RM, Elzoghby MA, Reames DL, Payne SC, Thorner MO, Marshall JC, Laws ER Jr & Vance ML. Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications, and predictors of outcome. Journal of Clinical Endocrinology and Metabolism 2011 96 2732-2740. (doi:10.1210/jc.2011-0554)
22. Wagenmakers MA, Netea-Maier RT, van Lindert EJ, Pieters GF, Grotenhuis AJ & Hermus AR. Results of endoscopic transsphenoidal pituitary surgery in 40 patients with a growth hormone-secreting macroadenoma. Acta Neurochirurgica 2011 153 1391-1399. (doi:10.1007/s00701-011-0959-8)
23. Netea-Maier RT, van Lindert EJ, den Heijer M, van der Eerden A, Pieters GF, Sweep CG, Grotenhuis JA & Hermus AR. Transsphenoidal pituitary surgery via the endoscopic technique: results in 35 consecutive patients with Cushing's disease. European Journal of Endocrinology 2006 154 675-684. (doi:10.1530/eje.1.02133)
24. Starke RM, Reames DL, Chen CJ, Laws ER & Jane JA Jr. Pure endoscopic transsphenoidal surgery for Cushing's disease: techniques, outcomes, and predictors of remission. Neurosurgery 2013 72 240-247. (doi:10.1227/NEU. 0b013e31827b966a)
25. Dehdashti AR & Gentili F. Current state of the art in the diagnosis and surgical treatment of Cushing disease: early experience with a purely endoscopic endonasal technique. Neurosurgical Focus 2007 23 E9. (doi:10.3171/foc.2007.23.3.11)
26. Jagannathan J, Sheehan JP & Jane JA Jr. Evaluation and management of Cushing syndrome in cases of negative sellar magnetic resonance imaging. Neurosurgical Focus 2007 23 E3. (doi:10.3171/foc.2007.23.3.4)
27. Oldfield EH. Editorial: unresolved issues: radiosurgery versus radiation therapy; medical suppression of growth hormone production during radiosurgery; and endoscopic surgery versus microscopic surgery. Neurosurgical Focus 2010 29 E16. (doi:10.3171/2010.8.FOCUS10215)
28. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM & Montori VM. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism 2008 93 1526-1540. (doi:10.1210/jc.2008-0125)
29. Wagenmakers MA, Netea-Maier RT, van Lindert EJ, Timmers HJ, Grotenhuis JA & Hermus AR. Repeated transsphenoidal pituitary surgery (TS) via the endoscopic technique: a good therapeutic option for recurrent or persistent Cushing's disease (CD). Clinical Endocrinology 2009 70 274-280. (doi:10.1111/j.1365-2265. 2008.03334.x)
30. Levy MJ, Jager HR, Powell M, Matharu MS, Meeran K & Goadsby PJ. Pituitary volume and headache: size is not everything. Archives of Neurology 2004 61 721-725. (doi:10.1001/archneur. 61.5.721)
31. Hardy J. Transsphenoidal microsurgical treatment of pituitary tumours. In Recent Advances in the Diagnosis and Treatment of Pituitary Tumours, pp 375-388. New York: Raven Press, 1979.
32. Knosp E, Steiner E, Kitz K & Matula C. Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 1993 33 610-617 (discussion 617-618). (doi:10.1227/00006123-199310000-00008)
33. Biller BM, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, Buchfelder M, Colao A, Hermus AR, Hofland LJ et al. Treatment of ACTH-dependent Cushing's syndrome: a consensus statement. Journal of Clinical Endocrinology and Metabolism 2008 93 2454-2462. (doi:10.1210/jc.2007-2734)
34. Yap LB, Turner HE, Adams CB & Wass JA. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit. Clinical Endocrinology 2002 56 25-31. (doi:10.1046/j.0300- 0664.2001.01444.x)
35. Fomekong E, Maiter D, Grandin C & Raftopoulos C. Outcome of transsphenoidal surgery for Cushing's disease: a high remission rate in ACTH-secreting macroadenomas. Clinical Neurology and Neurosurgery 2009 111 442-449. (doi:10.1016/j.clineuro.2008. 12.011)
36. De Tommasi C, Vance ML, Okonkwo DO, Diallo A & Laws ER Jr. Surgical management of adrenocorticotropic hormone-secreting macroadenomas: outcome and challenges in patients with Cushing's disease or Nelson's syndrome. Journal of Neurosurgery 2005 103 825-830. (doi:10.3171/jns.2005.103.5.0825)
37. Ceylan S, Koc K & Anik I. Endoscopic endonasal transsphenoidal approach for pituitary adenomas invading the cavernous sinus. Journal of Neurosurgery 2010 112 99-107. (doi:10.3171/2009.4. JNS09182)
38. Atkinson AB, Kennedy A,Wiggam MI, McCance DR & Sheridan B. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance. Clinical Endocrinology 2005 63 549-559. (doi:10.1111/j.1365-2265.2005.02380.x)
39. Chee GH, Mathias DB, James RA & Kendall-Taylor P. Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome? Clinical Endocrinology 2001 54 617-626. (doi:10.1046/j.1365-2265.2001.01261.x)